Mid-Afternoon Market Update: Nasdaq Jumps 400 Points; Sio Gene Therapies Shares Plummet

U.S. stocks extended gains toward the end of trading, with the Nasdaq Composite gaining more than 400 points on Thursday.

The Dow traded up 2.07% to 33,992.18 while the NASDAQ rose 3.39% to 12,912.18. The S&P also rose, gaining, 2.75% to 4,299.16.

Also check this: Executives Buy Around $65M Of 3 Stocks


Leading and Lagging Sectors


Communication services shares rose by 4.3% on Thursday. Meanwhile, top gainers in the sector included Meta Platforms, Inc. FB, up 18% and iHuman Inc. IH up 15%.


In trading on Thursday, utilities shares rose by just 0.9%.


Top Headline


The US economy contracted an annualized 1.4% on quarter during the first three months of the year, following a 6.9% growth in the previous quarter. Analysts, on the other hand, were expecting for a 1.1% growth.

 

Equities Trading UP


T Stamp Inc. IDAI shares shot up 140% to $5.03. Trust Stamp reported the launch of its Biometric Multi-Factor Authentication (Biometric MFATM) solution.


Shares of Swvl Holdings Corp. SWVL got a boost, shooting 47% to $9.91 after the company announced a definitive agreement to acquire Zeelo.


Statera Biopharma, Inc. STAB shares were also up, gaining 102% to $0.4219. Statera Biopharma entered into a non-binding term sheet with Immune Therapeutics Inc to sell its naltrexone and met-enkephalin rights.

 

Equities Trading DOWN

Teladoc Health, Inc. TDOC shares tumbled 40% to $33.42 after the company reported worse-than-expected Q1 sales results and issued FY22 sales guidance below analyst estimates.


Shares of GeoVax Labs, Inc. GOVX were down 21% to $0.8114 after the company reported a drop in Q1 sales.


Sio Gene Therapies Inc. SIOX was down, falling 48% to $0.3151 after the company issued a corporate update. The company will terminate its licensing agreement with the University of Massachusetts to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM2, for GM1 gangliosidosis and GM2 gangliosidosis, respectively. In parallel, the Company announced that it plans to explore and review a range of strategic alternatives.


Also check out: 2 Stocks Under $5 Insiders Are Aggressively Buying


Commodities

In commodity news, oil traded up 3.4% to $105.49, while gold traded up 0.2% to $1,893.10.


Silver traded down 0.9% Thursday to $23.245 while copper fell 0.7% to $4.4420.



Euro zone


European shares were higher today. The eurozone’s STOXX 600 gained 0.62%, London’s FTSE 100 gained 1.13%, while Spain’s IBEX 35 Index rose 0.41%. The German DAX climbed 1.35%, French CAC 40 rose 0.98% and Italy’s FTSE MIB Index climbed 0.95%.

Spanish annual inflation rate fell to 8.4% in April from around 40-year high level of 9.8% in March, while unemployment rate rose to 13.65% in the first quarter from 13.33% in the previous three-month period. UK car production dropped 33.4% year-over-year to 76,900 units in March.


Economics


The US economy contracted an annualized 1.4% on quarter during the first three months of the year, following a 6.9% growth in the previous quarter. Analysts, on the other hand, were expecting for a 1.1% growth.


US initial jobless claims dropped by 5,000 in the week ended April 23rd, from a revised reading of 185,000 in the prior period.


Check out this: Executives Buy Around $413M Of 3 Stocks


COVID-19 Update

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 82,888,240 cases with around 1,019,770 deaths. India confirmed a total of at least 43,068,790 cases and 522,690 deaths, while Brazil reported over 30,399,000 COVID-19 cases with 663,160 deaths. In total, there were at least 511,620,850 cases of COVID-19 worldwide with more than 6,253,660 deaths.

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsPenny StocksEurozoneCommoditiesSmall CapGlobalIntraday UpdateMarketsMid-Afternoon Market Update
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...